9th Aug 2006 16:00
AstraZeneca PLC09 August 2006 Dealing by DirectorCompanies Act 1985 Sections 324/329 Transaction by Person Discharging Managerial ResponsibilitiesDisclosure Rules DR 3.1.2R We hereby inform you that on 8 August 2006, David R Brennan, a Director of theCompany, exercised an option over 85,397 AstraZeneca PLC American DepositaryShares (ADSs) at an option price of $35.16 per ADS. One ADS equals one USD0.25Ordinary Share. The option was granted to Mr Brennan under the AstraZenecaShare Option Plan. We also inform you that on 8 August 2006, Mr Brennan sold the 85,397 ADSsacquired from the exercise at a price of $61.07 per ADS. Mr Brennan intends to use the sale proceeds, less the cost of exercising theoption and any applicable taxes, in connection with the purchase of a home inthe UK. As a result of the exercise and sale referred to above, Mr Brennan holds optionsover 355,246 ADSs and 110,641 Ordinary Shares of AstraZeneca PLC and has aninterest in 167,453 ADSs and 98,553 Ordinary Shares of the Company, whichrepresents approximately 0.017% of its issued ordinary capital. G H R MuskerCompany Secretary9 August 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca